Skip to main content
Top
Published in: Journal of Hematopathology 2/2020

01-06-2020 | Thalassemia | Original Article

Molecular spectrum and distribution of hemoglobinopathies in southwest of Iran: a seven-year retrospective study

Authors: Mina Ebrahimi, Javad Mohammadi-asl, Fakher Rahim

Published in: Journal of Hematopathology | Issue 2/2020

Login to get access

Abstract

Thalassemia is one of the most common inherited autosomal recessive disorders around the world. Over 200 mutations in the beta-globin gene and 70 mutations in the alpha-globin gene have been identified. This study aimed to assess a comprehensive prevalence of most frequent thalassemia mutations in Khuzestan Province, where is a belt of thalassemia in Iran. A total of 6946 subjects were enrolled for evaluating alpha-beta thalassemia from 2012 to 2018. In order to determine the silent mutations, subjects with microcytic hypochromic without anemia with normal Hb, HbA2, and HbF were included too. Genomic DNA was extracted, and ARMS-PCR, Gap-PCR, and DNA sequencing were used to detect thalassemia mutations. Of 6946 individuals, just 880 (12.6%) were normal, and 6066 (87.3%) were the carrier for thalassemia. The most frequent phenotype was alpha thalassemia (3984; 57.4%), followed by beta (1429; 20.6%), and alpha-beta thalassemia (653; 9.4%), respectively. The most frequent alpha mutation was − 3.7 (68.6%), followed by − α (6.2%), Codon 19 (2.9%), Poly A2 (2.7%), and − 5 nt (2.4%), respectively. In beta thalassemia, the more often mutations have been HbS (20.2%), IVSI-I (11.3%), Codon 36/37 (11.2%), and IVSI-110 (7.4%), respectively. Additional analysis showed that the most frequent genotypes in alpha and beta thalassemia were heterozygous carriers with − 3.7α (52.2%) and HbS (21.3%) mutations, respectively. The lowest Hb was found in heterozygote beta thalassemia carriers with IVSII-1β mutation (11.6 g/dl). Our findings showed that the distribution of beta thalassemia mutations differs from other previous data reported from Khuzestan and other provinces. This study is useful for screening and preventing thalassemia.
Appendix
Available only for authorised users
Literature
1.
go back to reference Weatherall DJ (2010) The inherited diseases of hemoglobin are an emerging global health burden. Blood 115(22):4331–4336CrossRef Weatherall DJ (2010) The inherited diseases of hemoglobin are an emerging global health burden. Blood 115(22):4331–4336CrossRef
2.
3.
go back to reference Mettananda S, Higgs DR (2018) Molecular basis and genetic modifiers of thalassemia. Hematol Oncol Clin North Am 32(2):237–245CrossRef Mettananda S, Higgs DR (2018) Molecular basis and genetic modifiers of thalassemia. Hematol Oncol Clin North Am 32(2):237–245CrossRef
4.
5.
go back to reference Al-Amodi AM et al (2018) Hemoglobin A2 (HbA2) has a measure of unreliability in diagnosing β-thalassemia trait (β-TT). Curr Med Res Opin Al-Amodi AM et al (2018) Hemoglobin A2 (HbA2) has a measure of unreliability in diagnosing β-thalassemia trait (β-TT). Curr Med Res Opin
6.
go back to reference Borges E, Wenning MRSC, Kimura EM, Gervásio SA, Costa FF, Sonati MF (2001) High prevalence of α-thalassemia among individuals with microcytosis and hypochromia without anemia. Brazilian J Med Biol Res Borges E, Wenning MRSC, Kimura EM, Gervásio SA, Costa FF, Sonati MF (2001) High prevalence of α-thalassemia among individuals with microcytosis and hypochromia without anemia. Brazilian J Med Biol Res
7.
go back to reference Sarookhani MR, Asiabanha M (2011) Spectrum of [alpha]-thalassemia mutations in Qazvin Province, Iran. African J Biotechnol 10(77):17690–17694 Sarookhani MR, Asiabanha M (2011) Spectrum of [alpha]-thalassemia mutations in Qazvin Province, Iran. African J Biotechnol 10(77):17690–17694
8.
go back to reference Celik MM, Gunesacar R, Oktay G, Duran GG, Kaya H (2013) Spectrum of α-thalassemia mutations including first observation of - -fil deletion in Hatay province, Turkey. Blood Cells Mol Dis 51(1):27–30CrossRef Celik MM, Gunesacar R, Oktay G, Duran GG, Kaya H (2013) Spectrum of α-thalassemia mutations including first observation of - -fil deletion in Hatay province, Turkey. Blood Cells Mol Dis 51(1):27–30CrossRef
9.
go back to reference Cai W-Q, Hu X-J, Xiong Q, Zhou B (2018) Prevalence and genotype analysis of newborn α-thalassemia in Wuhan area of China. Zhongguo Shi Yan Xue Ye Xue Za Zhi 26(1):219–222PubMed Cai W-Q, Hu X-J, Xiong Q, Zhou B (2018) Prevalence and genotype analysis of newborn α-thalassemia in Wuhan area of China. Zhongguo Shi Yan Xue Ye Xue Za Zhi 26(1):219–222PubMed
10.
go back to reference Baysal E (2011) α-Thalassemia syndromes in the United Arab Emirates. Hemoglobin Baysal E (2011) α-Thalassemia syndromes in the United Arab Emirates. Hemoglobin
11.
go back to reference Akhavan-Niaki H et al (2011) A comprehensive molecular characterization of beta thalassemia in a highly heterogeneous population. Blood Cells Mol Dis Akhavan-Niaki H et al (2011) A comprehensive molecular characterization of beta thalassemia in a highly heterogeneous population. Blood Cells Mol Dis
12.
go back to reference Najmabadi H et al (2006) Fourteen-year experience of prenatal diagnosis of thalassemia in Iran. Community Genet Najmabadi H et al (2006) Fourteen-year experience of prenatal diagnosis of thalassemia in Iran. Community Genet
13.
go back to reference Derakhshandeh-Peykar P, Akhavan-Niaki H, Tamaddoni A, Ghawidel-Parsa S, Naieni KH, Rahmani M, Babrzadeh F, Dilmaghani-Zadeh M, Farhud DD (2007) Distribution of β-thalassemia mutations in the northern provinces of Iran. Hemoglobin 31(3):351–356CrossRef Derakhshandeh-Peykar P, Akhavan-Niaki H, Tamaddoni A, Ghawidel-Parsa S, Naieni KH, Rahmani M, Babrzadeh F, Dilmaghani-Zadeh M, Farhud DD (2007) Distribution of β-thalassemia mutations in the northern provinces of Iran. Hemoglobin 31(3):351–356CrossRef
14.
go back to reference Kiani AA, Mortazavi Y, Zeinali S, Shirkhani Y (2007) The molecular analysis of β-thalassemia mutations in Lorestan Province, Iran. Hemoglobin Kiani AA, Mortazavi Y, Zeinali S, Shirkhani Y (2007) The molecular analysis of β-thalassemia mutations in Lorestan Province, Iran. Hemoglobin
15.
go back to reference Dehghanifard A et al (2013) Prenatal diagnosis of different polymorphisms of β-globin gene in Ahvaz. Int J Hematol Stem Cell Res Dehghanifard A et al (2013) Prenatal diagnosis of different polymorphisms of β-globin gene in Ahvaz. Int J Hematol Stem Cell Res
16.
go back to reference Saki N, Dorgalaleh A, Kashani Khatib Z, Alizadeh S, Rahim F, Galehdari H et al (2013) Prevalence of co-inheritance of alpha-thalassemia with beta-thalassemia and beta-hemoglobinopathy in Ahvaz City. J Ardabil Univ Med Sci 13(3):287–296 Saki N, Dorgalaleh A, Kashani Khatib Z, Alizadeh S, Rahim F, Galehdari H et al (2013) Prevalence of co-inheritance of alpha-thalassemia with beta-thalassemia and beta-hemoglobinopathy in Ahvaz City. J Ardabil Univ Med Sci 13(3):287–296
17.
go back to reference Rahimi Z (2013) Genetic epidemiology, hematological and clinical features of hemoglobinopathies in Iran. Biomed Res Int Rahimi Z (2013) Genetic epidemiology, hematological and clinical features of hemoglobinopathies in Iran. Biomed Res Int
18.
go back to reference Rahim F, Kaikhaei B, Zandian K, Hoseini A (2008) Co-inheritance of (alpha)-and (beta)-thalassemia in Khuzestan Province, Iran. Hematology 13(1):59–64CrossRef Rahim F, Kaikhaei B, Zandian K, Hoseini A (2008) Co-inheritance of (alpha)-and (beta)-thalassemia in Khuzestan Province, Iran. Hematology 13(1):59–64CrossRef
19.
go back to reference Keikhaei B, Slehi-fard P, Shariati G, Khosravi A (2018) Genetics of Iranian alpha-thalassemia patients: a comprehensive original study. Biochem Genet:1–16 Keikhaei B, Slehi-fard P, Shariati G, Khosravi A (2018) Genetics of Iranian alpha-thalassemia patients: a comprehensive original study. Biochem Genet:1–16
20.
go back to reference Hashemizadeh H, Noori R (2013) Premarital screening of Beta thalassemia minor in north-east of Iran. Iran J Pediatr Hematol Oncol Hashemizadeh H, Noori R (2013) Premarital screening of Beta thalassemia minor in north-east of Iran. Iran J Pediatr Hematol Oncol
21.
go back to reference Tosun F, Bilgin A, Kizilok A, Arpaci A, Yüreǧir GT (2006) Five-year evaluation of premarital screening program for hemoglobinopathies in the province of Mersin, Turkey. Turkish J Hematol Tosun F, Bilgin A, Kizilok A, Arpaci A, Yüreǧir GT (2006) Five-year evaluation of premarital screening program for hemoglobinopathies in the province of Mersin, Turkey. Turkish J Hematol
22.
go back to reference Rahiminejad MS, Zeinali S, Afrasiabi A, Kord Valeshabad A (2011) β-Thalassemia mutations found during 1 year of prenatal diagnoses in Fars province, Iran. Hemoglobin Rahiminejad MS, Zeinali S, Afrasiabi A, Kord Valeshabad A (2011) β-Thalassemia mutations found during 1 year of prenatal diagnoses in Fars province, Iran. Hemoglobin
23.
go back to reference Maryami F, Azarkeivan A, Fallah MS, Zeinali S (2015) A large cohort study of genotype and phenotype correlations of beta-thalassemia in Iranian population. Int J Hematol Stem Cell Res 9(4):198–202 Maryami F, Azarkeivan A, Fallah MS, Zeinali S (2015) A large cohort study of genotype and phenotype correlations of beta-thalassemia in Iranian population. Int J Hematol Stem Cell Res 9(4):198–202
24.
go back to reference He S, Li J, Li DM, Yi S, Lu X, Luo Y, Liang Y, Feng C, Chen B, Zheng C, Qiu X (2018) Molecular characterization of α- and β-thalassemia in the Yulin region of southern China. Gene 655:61–64CrossRef He S, Li J, Li DM, Yi S, Lu X, Luo Y, Liang Y, Feng C, Chen B, Zheng C, Qiu X (2018) Molecular characterization of α- and β-thalassemia in the Yulin region of southern China. Gene 655:61–64CrossRef
25.
go back to reference Tang W, Zhang C, Lu F, Tang J, Lu Y, Cui X, Qin X, Li S (2015) Spectrum of α-thalassemia and β-thalassemia mutations in the Guilin region of southern China. Clin Biochem 48(16–17):1068–1072CrossRef Tang W, Zhang C, Lu F, Tang J, Lu Y, Cui X, Qin X, Li S (2015) Spectrum of α-thalassemia and β-thalassemia mutations in the Guilin region of southern China. Clin Biochem 48(16–17):1068–1072CrossRef
26.
go back to reference Mettananda S, Gibbons RJ, Higgs DR (2015) α-Globin as a molecular target in the treatment of β-thalassemia. Blood 125(24):3694–3701CrossRef Mettananda S, Gibbons RJ, Higgs DR (2015) α-Globin as a molecular target in the treatment of β-thalassemia. Blood 125(24):3694–3701CrossRef
27.
go back to reference Voon HP, Vadolas J (2008) Controlling alpha-globin: a review of alpha-globin expression and its impact on beta-thalassemia. Haematologica Voon HP, Vadolas J (2008) Controlling alpha-globin: a review of alpha-globin expression and its impact on beta-thalassemia. Haematologica
28.
go back to reference Thein SL 2013 “Genetic association studies in β-hemoglobinopathies.,” Hematology/the Education Program of the American Society of Hematology. American Society of Hematology. Education ProgramCrossRef Thein SL 2013 “Genetic association studies in β-hemoglobinopathies.,” Hematology/the Education Program of the American Society of Hematology. American Society of Hematology. Education ProgramCrossRef
29.
go back to reference Fucharoen S and Viprakasit V 2009 “Hb H disease: clinical course and disease modifiers.,” Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education ProgramCrossRef Fucharoen S and Viprakasit V 2009 “Hb H disease: clinical course and disease modifiers.,” Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education ProgramCrossRef
30.
go back to reference Rahim F (2008) Genotyping of thalassemia in microcytic hypochromic anemia patients from southwest region of Iran. Pakistan J Med Sci Rahim F (2008) Genotyping of thalassemia in microcytic hypochromic anemia patients from southwest region of Iran. Pakistan J Med Sci
31.
go back to reference Doosti Irani A, Cheraghi Z, Bitaraf S, Cheraghi P, Safiri S (2015) Prevalence of alpha and beta-thalassemia mutations among carriers of thalassemia in Shadegan City, southwest of Iran. Zahedan J Res Med Sci 17(8) Doosti Irani A, Cheraghi Z, Bitaraf S, Cheraghi P, Safiri S (2015) Prevalence of alpha and beta-thalassemia mutations among carriers of thalassemia in Shadegan City, southwest of Iran. Zahedan J Res Med Sci 17(8)
32.
go back to reference Derakhshan SM, Khaniani MS, Afkhami F, PourFeizi AH (2016) Molecular study of deletional and nondeletional mutations on the α-globin locus in the Azeri population of northwestern Iran. Hemoglobin Derakhshan SM, Khaniani MS, Afkhami F, PourFeizi AH (2016) Molecular study of deletional and nondeletional mutations on the α-globin locus in the Azeri population of northwestern Iran. Hemoglobin
33.
go back to reference Bozdogan ST, Yuregir OO, Buyukkurt N, Aslan H, Ozdemir ZC, Gambin T (2015) Alpha-thalassemia mutations in Adana Province, southern Turkey: genotype-phenotype correlation. Indian J Hematol Blood Transfus Bozdogan ST, Yuregir OO, Buyukkurt N, Aslan H, Ozdemir ZC, Gambin T (2015) Alpha-thalassemia mutations in Adana Province, southern Turkey: genotype-phenotype correlation. Indian J Hematol Blood Transfus
34.
go back to reference Tamaddoni A, Hadavi V, Nejad NH, Khosh-Ain A, Siami R, Aghai-Meibodi J, Almadani N, Oberkanins C, Law HY, Najmabadi H (Jan. 2009) α-Thalassemia mutation analyses in Mazandaran province, North Iran. Hemoglobin 33(2):115–123CrossRef Tamaddoni A, Hadavi V, Nejad NH, Khosh-Ain A, Siami R, Aghai-Meibodi J, Almadani N, Oberkanins C, Law HY, Najmabadi H (Jan. 2009) α-Thalassemia mutation analyses in Mazandaran province, North Iran. Hemoglobin 33(2):115–123CrossRef
35.
go back to reference Oron-Karni V et al (2000) Diversity of α-globin mutations and clinical presentation of α-thalassemia in Israel. Am J Hematol Oron-Karni V et al (2000) Diversity of α-globin mutations and clinical presentation of α-thalassemia in Israel. Am J Hematol
36.
go back to reference Yin A et al (2014) The prevalence and molecular spectrum of α- and β-globin gene mutations in 14,332 families of Guangdong Province, China. PLoS One Yin A et al (2014) The prevalence and molecular spectrum of α- and β-globin gene mutations in 14,332 families of Guangdong Province, China. PLoS One
37.
go back to reference Wee YC et al (2008) Alpha-thalassaemia in association with beta-thalassaemia patients in Malaysia: a study on the co-inheritance of both disorders. Publ Health Genomics 11(3):129–134CrossRef Wee YC et al (2008) Alpha-thalassaemia in association with beta-thalassaemia patients in Malaysia: a study on the co-inheritance of both disorders. Publ Health Genomics 11(3):129–134CrossRef
38.
go back to reference Shakin SH, Liebhaber SA (1986) Translational profiles of alpha 1-, alpha 2-, and beta-globin messenger ribonucleic acids in human reticulocytes. J Clin Invest 78(4):1125–1129CrossRef Shakin SH, Liebhaber SA (1986) Translational profiles of alpha 1-, alpha 2-, and beta-globin messenger ribonucleic acids in human reticulocytes. J Clin Invest 78(4):1125–1129CrossRef
39.
go back to reference Farashi S, Harteveld CL (2018) Molecular basis of α-thalassemia. Blood Cells Molecules Dis 70:43–53CrossRef Farashi S, Harteveld CL (2018) Molecular basis of α-thalassemia. Blood Cells Molecules Dis 70:43–53CrossRef
40.
go back to reference Abolghasemi H et al (2007) Thalassemia in Iran: epidemiology, prevention, and management. J Pediatr Hematol Oncol 29(4):233–238CrossRef Abolghasemi H et al (2007) Thalassemia in Iran: epidemiology, prevention, and management. J Pediatr Hematol Oncol 29(4):233–238CrossRef
41.
go back to reference Mortazavi Y, Taheri S, Derakhshandeh J, Zeinali S (2008) Characterization of beta globin gene mutations in Zanjan Province: an introduction to prenatal diagnosis of thalassemia. 66(1):51–57 Mortazavi Y, Taheri S, Derakhshandeh J, Zeinali S (2008) Characterization of beta globin gene mutations in Zanjan Province: an introduction to prenatal diagnosis of thalassemia. 66(1):51–57
42.
go back to reference Derakhshan SM, Khorrami A (2015) Spectrum of β-globin gene mutations and β-thalassemia haplotype analysis among the Iranian Azeri Turkish population. Epidemiol Open Access 05(04) Derakhshan SM, Khorrami A (2015) Spectrum of β-globin gene mutations and β-thalassemia haplotype analysis among the Iranian Azeri Turkish population. Epidemiol Open Access 05(04)
43.
go back to reference Jaripour ME et al (2018) Mediterranean journal of hematology and infectious diseases prevalence of ß-thalassemia mutations among northeastern Iranian population and their impacts on hematological indices and application of prenatal diagnosis, a seven-years study. Mediterr J Hematol Infect Dis 10(1):2018042CrossRef Jaripour ME et al (2018) Mediterranean journal of hematology and infectious diseases prevalence of ß-thalassemia mutations among northeastern Iranian population and their impacts on hematological indices and application of prenatal diagnosis, a seven-years study. Mediterr J Hematol Infect Dis 10(1):2018042CrossRef
44.
go back to reference Ashtiani MTH et al (2009) Prevalence of haemoglobinopathies in 34 030 healthy adults in Tehran, Iran. J Clin Pathol Ashtiani MTH et al (2009) Prevalence of haemoglobinopathies in 34 030 healthy adults in Tehran, Iran. J Clin Pathol
45.
go back to reference Rahimi Z et al (2009) Haplotype analysis of beta thalassemia patients in Western Iran. Blood Cells Mol Dis Rahimi Z et al (2009) Haplotype analysis of beta thalassemia patients in Western Iran. Blood Cells Mol Dis
46.
go back to reference Yavarian M, Harteveld CL, Batelaan D, Bernini LF, Giordano PC (2001) Molecular spectrum of β-thalassemia in the Iranian Province of Hormozgan. Hemoglobin Yavarian M, Harteveld CL, Batelaan D, Bernini LF, Giordano PC (2001) Molecular spectrum of β-thalassemia in the Iranian Province of Hormozgan. Hemoglobin
Metadata
Title
Molecular spectrum and distribution of hemoglobinopathies in southwest of Iran: a seven-year retrospective study
Authors
Mina Ebrahimi
Javad Mohammadi-asl
Fakher Rahim
Publication date
01-06-2020
Publisher
Springer Berlin Heidelberg
Keyword
Thalassemia
Published in
Journal of Hematopathology / Issue 2/2020
Print ISSN: 1868-9256
Electronic ISSN: 1865-5785
DOI
https://doi.org/10.1007/s12308-020-00388-7

Other articles of this Issue 2/2020

Journal of Hematopathology 2/2020 Go to the issue